Reagent Kit for Quantitative Determination of 17α-Hydroxyprogesterone in Dried Blood Spots by Lanthanide Immunofluorescent Assay "17α-OH-PROGESTERONE-NEOSCREEN" (TU 9398-069-18619450-2008)

Reagent Kit for Quantitative Determination of 17α-Hydroxyprogesterone in Dried Blood Spots by Lanthanide Immunofluorescent Assay "17α-OH-PROGESTERONE-NEOSCREEN" (TU 9398-069-18619450-2008)

The "17α-OH-PROGESTERONE-NEOSCREEN" reagent kit is designed for the quantitative measurement of 17α-hydroxyprogesterone in dried blood spots using the lanthanide immunofluorescent assay method.

This product is intended for use in neonatal screening programs and complies with the requirements of TU 9398-069-18619450-2008.

The kit ensures high accuracy, reproducibility of results, and is suitable for in vitro laboratory diagnostics.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Reagent Kit for Quantitative Determination of 17α-Hydroxyprogesterone in Dried Blood Spots by Lanthanide Immunofluorescent Assay "17α-OH-PROGESTERONE-NEOSCREEN" (TU 9398-069-18619450-2008), then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.